Current role
Biotechnology · Healthcare
Board Member
2025-11-17–present
John Climaco
Board Member
CNS Pharmaceuticals, Inc. (CNSP)Equibles does not estimate personal net worth.
Get an email with a short summary when CNS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get CNSP alertsAbout John Climaco
John Climaco is recorded as Board Member at CNS Pharmaceuticals, Inc. (CNSP) since November 17, 2025. CNS Pharmaceuticals, Inc. reported in an 8-K filed December 17, 2025 that John Climaco resigned as member of the Company's Board of Directors, effective December 16, 2025. CNS Pharmaceuticals, Inc. reported in an 8-K filed December 17, 2025 that John Climaco resigned as chief executive officer, effective December 16, 2025. CNS Pharmaceuticals, Inc. reported in an 8-K filed November 21, 2025 that John Climaco was appointed Director, effective November 17, 2025. Equibles holds 4 filed executive changes naming John Climaco; each is listed under recent activity with its source filing. The proxy statement of CNS Pharmaceuticals, Inc. reports total compensation of $1,168,591 for John Climaco in fiscal 2025, including a base salary of $580,000. Disclosed compensation is on record for 8 fiscal years. CNS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CNS Pharmaceuticals, Inc. includes Rami Levin (CEO and Board Member), Faith Charles (Chairman and Board Member), Steve O'Loughlin (CFO) and 7 others.
“On December 16, 2025, John Climaco resigned from his positions as chief executive officer of CNS Pharmaceuticals, Inc. (the "Company") and as a member of the Company's Board of Directors, effective as of such date (the "Separation Date").”
“On December 16, 2025, John Climaco resigned from his positions as chief executive officer of CNS Pharmaceuticals, Inc. (the "Company") and as a member of the Company's Board of Directors, effective as of such date (the "Separation Date").”
Affiliation history
-
Current
2025-11-17–present
-
2025-11-17–2025-12-16
Company network
Leadership on record at CNS Pharmaceuticals, Inc.
- Rami Levin CEO, Board Member
- Faith Charles Chairman, Board Member
- Steve O'Loughlin CFO
- Eric Faulkner CTO
- Amy Mahery Board Member
- Bettina Cockroft Board Member
- Bettina M. Cockroft, M.D., M.B.A. Board Member
- Faith L. Charles Board Member
- Jeff Keyes Board Member
- Jeffrey Keyes Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CNS Pharmaceuticals, Inc. (CNSP) | Former Chief Executive Officer | $580,000 | $1,168,591 |
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Executive Officer | $525,000 | $1,103,680 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Executive Officer | $525,000 | $624,348 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Executive Officer | $525,000 | $827,928 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Executive Officer | $525,000 | $845,940 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | Chairman and Chief Executive Officer | $440,000 | $1,572,908 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | Chairman and Chief Executive Officer | $213,867 | $1,229,304 |
| 2018 | CNS Pharmaceuticals, Inc. (CNSP) | Chairman and Chief Executive Officer | $150,000 | $164,300 |